Bollong, M.J., Pietila, M., Pearson, A.D., Sarkar, T.R., Ahmad, I., Soundararajan, R., Lyssiotis, C.A., Mani, S.A., Schultz, P.G. and Lairson, L.L. (2017) A Vimentin Binding Small Molecule Leads to Mitotic Disruption in Mesenchymal Cancers. Proc Natl Acad Sci U S A 114 E9903-E9912. https://doi.org/10.1073/pnas.1716009114

has been cited by the following article:

• TITLE: The Expression of E-Cadherin and Vimentin in Non-Small-Cell Lung Cancer and Their Correlation with Epithelial-Mesenchymal Transition (EMT)

  AUTHORS: Mingyuan Tian, Yu Li

  KEYWORDS: Lung Cancer, E-Cadherin, Vimentin, EMT

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.6 No.5, May 21, 2018

  ABSTRACT: To investigate the expression of E-cadherin and Vimentin protein in non-small-cell lung cancer (NSCLC) and to analyze the relationship between their expression and epithelial-mesenchymal transition (EMT). Immuno-chemical staining with SP method was conducted to detect the protein expression of E-cadherin and Vimentin in 44 lung cancer tissues. E-cadherin was highly expressed in all normal lung tissues, and Vimentin was lowly expressed in all normal lung tissues. The expression rate of E-cadherin and Vimentin was 40.9% and 25.0% in NSCLC cases. The expressions of E-cadherin and Vimentin were not associated with gender, age, histopathological grading, lymphatic metastasis or smoking status (P > 0.05). But they were associated with clinical stage (P